Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

HAE US Equity

Haemonetics CorpHealth Care · Surgical & Medical Instruments & Apparatus · CIK 313143 · FY ends Mar 28
$108.41
+3.76 (+3.59%)
USD · as of 2026-08-19 · marketstack

Legal & controls

5 of 5 annual reports readable here

Item 3 and Item 9A as filed · every verdict is the registrant’s own sentence, printed below it · a filing that fails an extraction gate reads “not extracted”

Fiscal yearFiledItem 3ICFRdisclosure controlsmaterial weaknessFiling
2026-03-282026-05-20in the noteseffectiveeffectivenone in Item 9AEDGAR

Item 3 · Information with respect to this Item may be found in Note 15, Commitments & Contingencies, within the consolidated financial statements in Item 8 of this Annual Report on Form 10-K, which is incorporated herein by reference.

Item 9A · ICFR · Based on the Company’s assessment, the Company’s management believes that its internal controls over financial reporting were effective as of March 28, 2026.

Item 9A · disclosure controls · Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that, as of that date, the Company’s disclosure controls and procedures were effective.

2025-03-292025-05-21in the noteseffectiveeffectivenone in Item 9AEDGAR

Item 3 · Information with respect to this Item may be found in Note 15, Commitments & Contingencies, to the Consolidated Financial Statements in Item 8 of this Annual Report on Form 10-K, which is incorporated herein by reference.

Item 9A · ICFR · Based on our assessment, the Company’s management believes that its internal controls over financial reporting were effective as of March 29, 2025.

Item 9A · disclosure controls · Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that, as of that date, our disclosure controls and procedures were effective.

2024-03-302024-05-20in the noteseffectiveeffectivenone in Item 9AEDGAR

Item 3 · Information with respect to this Item may be found in Note 15, Commitments & Contingencies, to the Consolidated Financial Statements in Item 8 of this Annual Report on Form 10-K, which is incorporated herein by reference.

Item 9A · ICFR · Based on our assessment, the Company’s management believes that its internal controls over financial reporting were effective as of March 30, 2024.

Item 9A · disclosure controls · Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that, as of that date, our disclosure controls and procedures were effective.

2023-04-012023-05-22in the noteseffectiveeffectivenone in Item 9AEDGAR

Item 3 · Information with respect to this Item may be found in Note 16, Commitments & Contingencies, to the Consolidated Financial Statements in Item 8 of this Annual Report on Form 10-K, which is incorporated herein by reference.

Item 9A · ICFR · Based on our assessment, the Company’s management believes that its internal controls over financial reporting were effective as of April 1, 2023.

Item 9A · disclosure controls · Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that, as of that date, our disclosure controls and procedures were effective.

2022-04-022022-05-25in the noteseffectiveeffectivenone in Item 9AEDGAR

Item 3 · Information with respect to this Item may be found in Note 16, Commitments & Contingencies, to the Consolidated Financial Statements in Item 8 of this Annual Report on Form 10-K, which is incorporated herein by reference.

Item 9A · ICFR · Based on our assessment, the Company's management believes that its internal controls over financial reporting were effective as of April 2, 2022.

Item 9A · disclosure controls · Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that, as of that date, our disclosure controls and procedures were effective.

5 of 5 annual reports on record have their filing text cached on this host; the rest are listed with their EDGAR link and no extraction, because this surface never fetches from SEC on a page load.

  • Item 3 and Item 9A are located in the filing HTML already cached on this host and read with the same line-anchored item matcher and largest-gap body disambiguation the filing-narrative pass uses for Item 1A and Item 7 — no fetch, no model, no summarization.
  • A heading is accepted as a section only when it is not a table-of-contents row (a trailing page number), not a quoted reference in prose, and names its own section; the span must then clear a per-item length band and carry readable text after the heading. Anything that fails a gate is served as 'not extracted' with the reason — never as a default value.
  • An effectiveness conclusion is read only from a sentence that names its own control set (disclosure controls and procedures, or internal control over financial reporting) and states an outcome. Conditional sentences — the standard limitations paragraph and forward-looking remediation language — are excluded, because they are hypotheses rather than conclusions.
  • When a filing's own sentences disagree — an effective conclusion beside an unremediated material-weakness disclosure, or two conclusions of opposite sign — no verdict is asserted. A wrong 'controls were effective' reading is worse than no reading.
  • Every verdict is shown beside the verbatim sentence it was read from. The excerpt is the filing's own words, capped at 1,200 characters; the filing itself is one link away.